Cancer Research UK, Canary Center at Stanford, and OHSU Knight Cancer Institute present the Early Detection of Cancer Conference series. The annual conference brings together experts in early detection from multiple disciplines to share groundbreaking research and progress in the field.

The Conference is part of a long-term commitment to invest in early detection research, to understand the biology behind early-stage cancers, find new detection and screening methods, and enhance uptake and accuracy of screening.

Harmeet Dhani, MD, MSc, Medical Director, Biological Dynamics, presented a lightning talk on “Proteomic Expression Using Exosomes in Intraductal Papillary Mucinous Neoplasms (IPMN) Patients to Inform Risk Stratification," as part of the “Understanding Pre-cancers to Enable Early Detection” track.

The lightning talk demonstrates the ability of the ExoVita Pancreas assay to risk-stratify Intraductal Papillary Mucinous Neoplasms (IPMNs), the most common type of pancreatic cyst, in order to help inform treatment decisions for patients at risk of pancreatic cancer.